WCM Investment Management Portfolio holdings
AUM
$43.8B
1-Year Return
46.92%
This Quarter Return
+12.82%
1 Year Return
+46.92%
3 Year Return
+145.55%
5 Year Return
+234.7%
10 Year Return
+793.48%
AUM
$16B
AUM Growth
+$1.58B
(+11%)
Cap. Flow
-$92.6M
Cap. Flow
% of AUM
-0.58%
Top 10 Holdings %
Top 10 Hldgs %
74.25%
Holding
161
New
19
Increased
54
Reduced
75
Closed
10
Top Buys
| 1 |
Alcon
ALC
|
$250M |
| 2 |
Chubb
CB
|
$72.7M |
| 3 |
Illumina
ILMN
|
$66.6M |
| 4 |
HDFC Bank
HDB
|
$49.6M |
| 5 |
Mettler-Toledo International
MTD
|
$44.4M |
Top Sells
| 1 |
Ryanair
RYAAY
|
$325M |
| 2 |
Shopify
SHOP
|
$321M |
| 3 |
Core Laboratories
CLB
|
$215M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
$85.4M |
| 5 |
Cooper Companies
COO
|
$61.9M |
Sector Composition
| 1 | Technology | 30.38% |
| 2 | Healthcare | 26.61% |
| 3 | Financials | 23.75% |
| 4 | Industrials | 11.08% |
| 5 | Materials | 1.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Etsy
ETSY
$5.32B
| $1.08M | 0.01% |
17,623
-352
| -2% | -$21.6K |
|
127
LivaNova
LIVN
$3.16B
| $948K | 0.01% |
13,174
-371
| -3% | -$26.7K |
|
128
Dave & Buster's
PLAY
$816M
| $932K | 0.01% |
23,039
-355
| -2% | -$14.4K |
|
|
MNDT
129
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $916K | 0.01% |
61,798
-1,338
| -2% | -$19.8K |
|
130
nLIGHT
LASR
$1.4B
| $902K | 0.01% |
46,984
-725
| -2% | -$13.9K |
|
131
Synopsys
SNPS
$111B
| $867K | 0.01% |
6,735
+3,945
| +141% | +$508K |
|
132
Shutterstock
SSTK
$719M
| $838K | 0.01% |
21,377
-5,482
| -20% | -$215K |
|
|
LOGM
133
DELISTED
LogMein, Inc.
LOGM
| $812K | 0.01% |
11,014
-2,832
| -20% | -$209K |
|
|
RETA
134
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $804K | 0.01% |
8,529
-273
| -3% | -$25.7K |
|
135
Tradeweb Markets
TW
$25.4B
| $777K | ﹤0.01% |
+17,725
| New | +$777K |
|
136
Yelp
YELP
$2.01B
| $756K | ﹤0.01% |
22,121
-340
| -2% | -$11.6K |
|
137
Workday
WDAY
$62.3B
| $720K | ﹤0.01% |
3,500
| – | – |
|
138
Ligand Pharmaceuticals
LGND
$3.26B
| $666K | ﹤0.01% |
9,347
+4,772
| +104% | +$340K |
|
139
Halozyme
HALO
$8.63B
| $541K | ﹤0.01% |
31,512
-485
| -2% | -$8.33K |
|
|
XLRN
140
DELISTED
Acceleron Pharma Inc.
XLRN
| $528K | ﹤0.01% |
+12,851
| New | +$528K |
|
|
BPMC
141
DELISTED
Blueprint Medicines
BPMC
| $518K | ﹤0.01% |
+5,495
| New | +$518K |
|
142
Surgery Partners
SGRY
$2.87B
| $505K | ﹤0.01% |
62,019
-1,528
| -2% | -$12.4K |
|
143
iShares MSCI EAFE ETF
EFA
$66.1B
| $432K | ﹤0.01% |
+6,575
| New | +$432K |
|
144
FibroGen
FGEN
$46.1M
| $407K | ﹤0.01% |
360
-6
| -2% | -$6.78K |
|
|
BHVN
145
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $386K | ﹤0.01% |
8,818
-132
| -1% | -$5.78K |
|
146
Kura Oncology
KURA
$724M
| $374K | ﹤0.01% |
18,994
-294
| -2% | -$5.79K |
|
147
Heron Therapeutics
HRTX
$198M
| $316K | ﹤0.01% |
17,004
-263
| -2% | -$4.89K |
|
148
Nice
NICE
$8.64B
| $229K | ﹤0.01% |
1,671
| – | – |
|
149
Sony
SONY
$165B
| $208K | ﹤0.01% |
+19,890
| New | +$208K |
|
150
CGI
GIB
$21.4B
| $204K | ﹤0.01% |
+2,660
| New | +$204K |
|